[Tickers Inside] 7 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. --------------------------------------------------------------- [Elon Musk is Worried about China]( [See here why lithium could surge much higher.]() --------------------------------------------------------------- August 16, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 7 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- [Want To Catch The Next Hot Investing Trend (Look Inside?)]() While millennials are trying to get rich in crypto Ponzi schemes- there's something happening that Wall Street is TOTALLY ignoring. And it's about to affect every American Citizen over 55... [And It Could Spark An Economic Boom For American Investors]() --------------------------------------------------------------- [FlexShopper, FPAY](=) Recent Analyst Action: Michael Diana, analyst at Maxim Group, reiterates coverage on [FlexShopper (FPAY)]()in the Financial sector with a Buy rating and a price target of $2.5 (4 days ago). - Recent Price: $$2.7 - Average Analyst Price Target: $3.25 (20.37%) - Market Cap: $$49.69M [TipRanks.com]( also reports that [FlexShopper]()currently has 2 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $3.25. The target pricing ranges from a high forecast of $4.00 down to a low forecast of $2.50. [FlexShopper (FPAY)]()’s last closing price was $2.7 which would put the average price target at $3.25. Here are 3rd party ratings for [FPAY](=): - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Strong Buy, Bottom 33% (168 out of 252) [Click here for chart >>]() -------------------------------------------------------------------------- --------------------------------------------------------------- [Warning: Why your IRA could crash on September 21st]() China will attack Taiwan as soon as September 21st, 2022. The stock market will crash at least 35% when China makes their move. [Here are the 3 steps you can take to protect your retirement.]() = --------------------------------------------------------------- [Terns Pharmaceuticals, TERN]( Recent Analyst Action: Eric Joseph, analyst at J.P. Morgan, reiterates coverage on [Terns Pharmaceuticals (TERN)](in the Healthcare sector with a Hold rating and a price target of $5 (1 week ago). - Recent Price: $$4.81 - Average Analyst Price Target: $5.00 (3.95%) - Market Cap: $$165.50M [TipRanks.com]() also reports that [Terns Pharmaceuticals]()currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $5.00. The target pricing ranges from a high forecast of $5.00 down to a low forecast of $5.00. [Terns Pharmaceuticals (TERN)](’s last closing price was $4.81 which would put the average price target at $5.00. Here are 3rd party ratings for [TERN](: - TipRanks.com: Hold - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: buy - Zacks.com: Buy, Top 27% (69 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- [Vacasa, VCSA](=) Recent Analyst Action: Eric Sheridan, analyst at Goldman Sachs, reiterates coverage on [Vacasa (VCSA)](in the Financial sector with a Hold rating and a price target of $6 (5 days ago). - Recent Price: $$5.5 - Average Analyst Price Target: $7.50 (36.36%) - Market Cap: $$2.59B [TipRanks.com](=) also reports that [Vacasa](currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $7.50. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $6.00. [Vacasa (VCSA)](’s last closing price was $5.5 which would put the average price target at $7.50. Here are 3rd party ratings for [VCSA](: - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: n/a - Zacks.com: Buy, Bottom 44% (141 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- ["White Gold" is the New Oil]() The green revolution is here and creating a massive demand for this critical material. However, China has almost total control of the world's supply. And one under the radar company is poised to break that stranglehold. For investors, the time is now. [Read this free report before it gets the attention of Wall Street.]() --------------------------------------------------------------- [Veru, VERU](=) Recent Analyst Action: Yi Chen, analyst at H.C. Wainwright, reiterates coverage on [Veru (VERU)](in the Healthcare sector with a Buy rating and a price target of $24 (4 days ago). - Recent Price: $$23.52 - Average Analyst Price Target: $30.25 (28.61%) - Market Cap: $$1.57B [TipRanks.com]() also reports that [Veru](=)currently has 5 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $30.25. The target pricing ranges from a high forecast of $36.00 down to a low forecast of $24.00. [Veru (VERU)](=)’s last closing price was $23.52 which would put the average price target at $30.25. Here are 3rd party ratings for [VERU](: - TipRanks.com: Strong Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Hold, Bottom 41% (149 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Enovix, ENVX](=) Recent Analyst Action: Gus Richard, analyst at Northland Securities, reiterates coverage on [Enovix (ENVX)](=)in the Industrial Goods sector with a Buy rating and a price target of $25 (5 days ago). - Recent Price: $$25.98 - Average Analyst Price Target: $22.50 (-13.39%) - Market Cap: $$3.89B [TipRanks.com]( also reports that [Enovix](=)currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $22.50 . The target pricing ranges from a high forecast of $25.00 down to a low forecast of $20.00. [Enovix (ENVX)](=)’s last closing price was $25.98 which would put the average price target at $22.50. Here are 3rd party ratings for [ENVX](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: buy - Zacks.com: Hold, Top 27% (69 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [America's Next Billion-Dollar Startup Is Waiting to Be Discovered]( next Etsy, Clubhouse, and Roku are out there, and we’re assembling a team of rockstar angel investors to find them. But we can’t do it without your help! [Join us here.]() --------------------------------------------------------------- [Navitas Semiconductor, NVTS](=) Recent Analyst Action: Quinn Bolton, analyst at Needham, reiterates coverage on [Navitas Semiconductor (NVTS)](in the Technology sector with a Buy rating and a price target of $8 (12 hours ago). - Recent Price: $$7.57 - Average Analyst Price Target: $8.00 (5.68%) - Market Cap: $$761.94M [TipRanks.com]() also reports that [Navitas Semiconductor](=)currently has 4 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $8.00. The target pricing ranges from a high forecast of $12.00 down to a low forecast of $5.00. [Navitas Semiconductor (NVTS)](=)’s last closing price was $7.57 which would put the average price target at $8.00. Here are 3rd party ratings for [NVTS](=): - TipRanks.com: Strong Buy - TradingView.com: Buy - Yahoo! Finance: Bearish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Bottom 47% (133 out of 252) [Click here for chart >>]( -------------------------------------------------------------------------- [Genprex, GNPX](=) Recent Analyst Action: Robert LeBoyer, analyst at Noble Financial, reiterates coverage on [Genprex (GNPX)](=)in the Healthcare sector with a Buy rating and a price target of $5 (7 months ago). - Recent Price: $$2.33 - Average Analyst Price Target: $5.00 (114.59%) - Market Cap: $$100.11M [TipRanks.com]() also reports that [Genprex](=)currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $5.00. The target pricing ranges from a high forecast of $5.00 down to a low forecast of $5.00. [Genprex (GNPX)](=)’s last closing price was $2.33 which would put the average price target at $5.00. Here are 3rd party ratings for [GNPX](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Top 27% (69 out of 252) [Click here for chart >>](=) -------------------------------------------------------------------------- --------------------------------------------------------------- [The WORST National Security Threat To The USA Since The 1973 Arab Oil Embargo?]() Communist China has the USA in a resource stranglehold. They have a monopoly on this CRITICAL metal that we desperately need for military technology. In fact, both Trump AND Biden passed executive orders that addressed this crisis. And it could have a massive effect on smart investor's bank accounts. [See This Growing National Security Threat Here]() = --------------------------------------------------------------- And there you have it--7 Five Day Gainers of all US Exchanges. Sincerely, Editor, MarketSectorDaily.com [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954 If you no longer wish to receive our emails, click the link below: [Unsubscribe]( Sandpiper Marketing Group, LLC PO Box 407 Mt. Mourne, North Carolina 28123 United States (845) 803-0954